American Well Corporation (AMWL) (AMWL)
American Well Corporation (AMWL) is a telehealth software company enabling digital healthcare delivery. They provide a platform for various medical services and telemedicine equipment.
Company Overview
American Well Corporation (AMWL) pioneers digital healthcare delivery through its comprehensive telehealth platform, offering diverse medical services and telemedicine solutions, positioning it as a key player in the rapidly expanding virtual care market despite current profitability challenges.
Investment Thesis
Investing in American Well Corporation (AMWL) presents a speculative opportunity in the growing telehealth market. While the company's current P/E ratio of -0.63 and a negative profit margin of -42.8% raise concerns, the increasing adoption of telehealth services could drive future growth. Key value drivers include expanding partnerships with healthcare providers and insurers, increasing utilization of telehealth services, and potential cost savings from virtual care delivery. The company's beta of 1.40 suggests higher volatility compared to the market. Upcoming catalysts include new product launches and strategic collaborations. Success hinges on Amwell's ability to achieve profitability and capture a larger share of the telehealth market.
Key Highlights
- Market Cap of $0.07B reflects its current valuation in the telehealth market.
- Negative P/E ratio of -0.63 indicates current unprofitability.
- Gross Margin of 39.7% demonstrates the potential for profitability with increased scale.
- Profit Margin of -42.8% highlights the challenges in achieving profitability in the competitive telehealth market.
- Beta of 1.40 suggests higher volatility compared to the market.
Competitors
Strengths
- Comprehensive telehealth platform with diverse service offerings.
- Established partnerships with health systems and insurers.
- Proprietary technology and software solutions.
- Experienced management team with expertise in telehealth.
Weaknesses
- Negative profit margin and ongoing losses.
- High competition in the telehealth market.
- Dependence on regulatory changes and reimbursement policies.
- Relatively small market capitalization.
Catalysts
- Upcoming: New product launches and platform enhancements.
- Ongoing: Expansion of partnerships with health systems and insurers.
- Ongoing: Increasing utilization of telehealth services.
- Ongoing: Positive regulatory changes and reimbursement policies.
Risks
- Potential: Increasing competition from other telehealth providers.
- Potential: Changes in regulatory policies and reimbursement rates.
- Potential: Data security and privacy breaches.
- Ongoing: Negative profit margin and ongoing losses.
- Ongoing: Dependence on technology and internet connectivity.
Growth Opportunities
- Expanding partnerships with health systems and insurers: Amwell can drive growth by forging deeper integrations with established healthcare providers and insurance companies. These partnerships can increase the reach of Amwell's telehealth platform and drive higher utilization rates. The market for telehealth partnerships is substantial, with health systems and insurers increasingly seeking to expand their virtual care offerings. Timeline: Ongoing.
- Increasing utilization of telehealth services: Amwell can focus on driving greater adoption of its telehealth services among patients and providers. This can be achieved through targeted marketing campaigns, educational initiatives, and user-friendly platform enhancements. The market for telehealth services is projected to reach billions of dollars in the coming years, driven by increasing demand for convenient and accessible healthcare. Timeline: Ongoing.
- Developing new telehealth solutions: Amwell can expand its product offerings to include new telehealth solutions that address unmet needs in the healthcare market. This could include specialized programs for chronic disease management, mental health support, and remote patient monitoring. The market for specialized telehealth solutions is growing rapidly, driven by the increasing prevalence of chronic diseases and the need for more personalized care. Timeline: Ongoing.
- Leveraging artificial intelligence and machine learning: Amwell can integrate AI and machine learning technologies into its platform to improve the efficiency and effectiveness of telehealth services. This could include using AI to triage patients, personalize treatment plans, and automate administrative tasks. The market for AI in healthcare is projected to reach billions of dollars in the coming years, driven by the potential to improve patient outcomes and reduce healthcare costs. Timeline: Ongoing.
- Expanding into new geographic markets: Amwell can expand its operations into new geographic markets to reach a wider customer base. This could include targeting international markets with high demand for telehealth services. The global telehealth market is growing rapidly, driven by increasing demand for convenient and accessible healthcare solutions in developing countries. Timeline: Ongoing.
Opportunities
- Expanding partnerships with health systems and insurers.
- Increasing utilization of telehealth services.
- Developing new telehealth solutions for chronic disease management and mental health.
- Leveraging AI and machine learning to improve efficiency and effectiveness.
Threats
- Increasing competition from other telehealth providers.
- Changes in regulatory policies and reimbursement rates.
- Data security and privacy concerns.
- Potential for technological obsolescence.
Competitive Advantages
- Established telehealth platform with a wide range of services.
- Partnerships with leading health systems and insurers.
- Proprietary technology and software solutions.
- Brand recognition and reputation in the telehealth market.
About
American Well Corporation, now known as Amwell, was founded in 2006 with the mission of transforming healthcare delivery through technology. Recognizing the potential of telehealth to improve access and convenience, the company developed a platform that connects patients with doctors and other healthcare providers remotely. Over the years, Amwell has expanded its offerings to include a wide range of services, from urgent care and scheduled visits to specialized medical consultations such as telestroke and behavioral health. The company's platform supports various care settings, including homes, schools, and retail clinics. Amwell also provides telemedicine equipment, such as carts, peripherals, and kiosks, to facilitate virtual care delivery. Headquartered in Boston, Massachusetts, Amwell has established itself as a leading telehealth provider, partnering with health systems, insurers, and employers to deliver digital healthcare solutions. Despite its innovative approach, Amwell faces competition from other telehealth providers and traditional healthcare models, requiring continuous adaptation and strategic partnerships to maintain its market position.
What They Do
- Provides a telehealth platform for digital healthcare delivery.
- Offers urgent care services through virtual consultations.
- Facilitates scheduled visits with healthcare providers remotely.
- Delivers acute behavioral health services via telehealth.
- Supports telestroke consultations for timely stroke care.
- Offers pediatric telehealth services for children's healthcare needs.
- Provides telemedicine equipment such as carts and peripherals.
Business Model
- Generates revenue through subscription fees from health systems and insurers.
- Charges per-visit fees for telehealth consultations.
- Sells telemedicine equipment to healthcare providers.
- Offers software licensing for its telehealth platform.
Industry Context
American Well Corporation operates within the rapidly evolving telehealth industry. The market is driven by increasing demand for convenient and accessible healthcare solutions, advancements in technology, and favorable regulatory changes. The telehealth market is expected to continue growing at a rapid pace, driven by factors such as aging populations, rising healthcare costs, and increasing prevalence of chronic diseases. Competitors include companies like Advaxis (ADVM), Alexo Therapeutics (ALXO), Atyr Pharma (ATYR), Bionomics (BMEA), and Camping World Holdings (CAMP), each vying for market share with different approaches to telehealth services. Amwell's success depends on its ability to differentiate itself through technology, partnerships, and service offerings.
Key Customers
- Health systems seeking to expand their virtual care offerings.
- Insurers looking to reduce healthcare costs and improve access to care.
- Employers providing telehealth benefits to their employees.
- Patients seeking convenient and affordable healthcare services.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $55M | -$25M | $0.00 |
| Q3 2025 | $56M | -$32M | $0.00 |
| Q2 2025 | $71M | -$20M | $0.00 |
| Q1 2025 | $67M | -$19M | $0.00 |
Source: Company filings
Chart & Info
Price Chart
American Well Corporation (AMWL) (AMWL) stock price: $5.21 (+0.36, +7.42%)
Latest News
-
Hims & Hers Accelerates AI Preventive Care and Platform Strategy
Zacks · Feb 20, 2026
-
Earnings Scheduled For February 12, 2026
benzinga · Feb 12, 2026
-
Earnings Scheduled For November 4, 2025
benzinga · Nov 4, 2025
-
Earnings Scheduled For August 5, 2025
benzinga · Aug 5, 2025
Technical Analysis
Rationale
AI-generated technical analysis for AMWL including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss American Well Corporation (AMWL) (AMWL) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for AMWL.
Make a Prediction
Set your price target for American Well Corporation (AMWL) (AMWL), choose a timeframe, and track your prediction accuracy.
Current price: $5.21
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMWL.
Price Targets
Wall Street price target analysis for AMWL.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 2/100
Revenue declined -2.0% YoY, signaling shrinking demand or market headwinds.
-
Gross Margin 8/100
Gross margin at 53.8% indicates good unit economics and healthy profitability per sale.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates AMWL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Frequently Asked Questions
What does American Well Corporation do?
American Well Corporation (Amwell) operates as a telehealth software company that enables the digital delivery of care. They provide a platform connecting patients with healthcare providers for various services, including urgent care, scheduled visits, and specialized consultations. Amwell's platform supports different care settings, such as homes, schools, and retail clinics. They also offer telemedicine equipment like carts and peripherals, facilitating virtual care. Amwell generates revenue through subscription fees, per-visit charges, and equipment sales, positioning itself as a key player in the evolving telehealth market.
Is AMWL stock a good buy?
AMWL stock presents a speculative investment opportunity. While the company's negative P/E ratio and profit margin raise concerns, the growing telehealth market offers potential upside. Key factors to consider include Amwell's partnerships, utilization rates, and cost savings from virtual care. Investors should weigh the risks of competition and regulatory changes against the potential for future growth. A successful investment hinges on Amwell's ability to achieve profitability and capture a larger share of the telehealth market, making it a high-risk, high-reward opportunity.
What are the main risks for AMWL?
The main risks for AMWL include increasing competition in the telehealth market, which could pressure pricing and market share. Changes in regulatory policies and reimbursement rates could negatively impact revenue. Data security and privacy breaches pose a significant threat, potentially damaging the company's reputation and leading to financial losses. Additionally, AMWL faces the ongoing challenge of achieving profitability and managing its expenses. Dependence on technology and internet connectivity also presents a risk, as disruptions could impact service delivery.
Is AMWL a good stock to buy?
Whether AMWL is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the AMWL MoonshotScore?
The MoonshotScore for AMWL is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is AMWL data updated?
AMWL stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to AMWL is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for AMWL?
Growth catalysts for American Well Corporation (AMWL) (AMWL) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes American Well Corporation (AMWL)'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are AMWL's main competitors?
American Well Corporation (AMWL) (AMWL) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether AMWL has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about AMWL?
Wall Street analyst coverage for AMWL includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is AMWL's market cap?
Market capitalization (market cap) for AMWL is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows AMWL's current market cap alongside enterprise value and other valuation metrics.
How has AMWL stock performed recently?
AMWL's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing AMWL's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in AMWL?
Key risk categories for AMWL include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures AMWL's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling AMWL?
Insider trading activity for AMWL tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is AMWL a good stock for beginners?
American Well Corporation (AMWL) (AMWL) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is AMWL for first-time investors?
Every stock carries risk, including American Well Corporation (AMWL) (AMWL). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like AMWL.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- The telehealth market is subject to rapid changes and regulatory uncertainties.